Skip to content

Clinical trials

Phase 3 Glucose Intolerance trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glucose Intolerance Phase: Phase 3 Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20032
20043
20055
20063
20071
20092
20113
20121
20131
20141
20183
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Unknown status5
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gerstein, Hertzel, MD2
IRCCS San Raffaele2
Novartis2
Sanofi2
Takeda2
Woman's2
Aga Khan University1
Bayer1
Daiichi Sankyo1
Fondazione per la ricerca sulla Fibrosi Cistica1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glucose Intolerance32
Diabetes Mellitus, Type 210
Diabetes Mellitus6
Insulin Resistance6
Prediabetic State5
Cardiovascular Diseases4
Metabolic Syndrome4
Hyperglycemia3
Coronary Artery Disease2
Atherosclerosis1

Trials

Showing 26 to 32 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.